Literature DB >> 2007510

[Comparison of the adverse effect profile of different substances such as penicillins, tetracyclines, sulfonamides and quinolones].

H Keller1.   

Abstract

The penicillins, the tetracyclines and the sulfonamides have often been used in the last few decades in spite of their well-known side effects. Hypersensitivity reactions to penicillins are among the most important adverse reactions in these antibiotics; in every case a careful medical history has to be taken before a new course of penicillin treatment. The use of tetracyclines in women during the last six months of pregnancy or in children under the age of eight years is contraindicated. Patients with severe blood, kidney or liver disease should not be treated with sulfonamides. Toxic reactions to penicillin even with convulsions may occur in patients with renal insufficiency if the dosage is not adapted. The fluoroquinolones do not seem to have greater risks regarding adverse reactions than the historical compounds mentioned. Neurotoxicity is an important problem. Mild reactions are reported with incidences under 2%; severe neurotoxic side effects that require interruption of therapy are rare. Psychotic reactions, hallucinations, depressions and grand mal convulsions also belong to this category. Other side effects (skin, GI-tract) are no more frequent than with the classical antibiotics. In patients with renal insufficiency the dosage of ofloxacin has to be adapted. The cartilage lesions which are seen in juvenile rats and dogs raise the question whether or not the cases of arthralgia during therapy with older quinolones as well as under treatment with fluoroquinolones have a causal relationship. Up to date quinolones should not be prescribed in children and young adults except in cases with cystic fibrosis. The development of resistance has not been a significant problem so far.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2007510     DOI: 10.1007/bf01644730

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  12 in total

Review 1.  Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors:  J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

2.  Fatal vasculitis associated with ofloxacin.

Authors:  J L Pace; P Gatt
Journal:  BMJ       Date:  1989-09-09

3.  Hypersensitivity vasculitis due to ofloxacin.

Authors:  D Huminer; J D Cohen; R Majadla; S Dux
Journal:  BMJ       Date:  1989-07-29

Review 4.  Post-marketing surveillance of the quinolones: a view from Great Britain.

Authors:  P G Davey
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

5.  Psychotoxic effects of ofloxacin.

Authors:  M Zaudig; M von Bose; M M Weber; D Bremer; W Zieglgänsberger
Journal:  Pharmacopsychiatry       Date:  1989-01       Impact factor: 5.788

6.  Crystalluria and ciprofloxacin, influence of urinary pH and hydration.

Authors:  S B Thorsteinsson; T Bergan; S Oddsdottir; R Rohwedder; R Holm
Journal:  Chemotherapy       Date:  1986       Impact factor: 2.544

Review 7.  [Joint tolerance of pefloxacin and ofloxacin in children and adolescents with cystic fibrosis].

Authors:  E Pertuiset; G Lenoir; M Jehanne; F Douchain; M Guillot; C J Menkès
Journal:  Rev Rhum Mal Osteoartic       Date:  1989-11

8.  The safety profile of ofloxacin.

Authors:  K J Tack; J A Smith
Journal:  Am J Med       Date:  1989-12-29       Impact factor: 4.965

Review 9.  Adverse reactions and interactions of fluoroquinolones.

Authors:  P Ball
Journal:  Clin Invest Med       Date:  1989-02       Impact factor: 0.825

Review 10.  Drug-drug interactions with ciprofloxacin and other fluoroquinolones.

Authors:  R E Polk
Journal:  Am J Med       Date:  1989-11-30       Impact factor: 4.965

View more
  2 in total

Review 1.  Drug-induced cognitive impairment in the elderly.

Authors:  A R Moore; S T O'Keeffe
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

Review 2.  Hidradenitis suppurativa in children and adolescents: a review of treatment options.

Authors:  Peter Riis Mikkelsen; Gregor B E Jemec
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.